Back to today’s briefing

Story perspectives

Revolutionary Crispr-Cas13 Targets Influenza: A Dual Approach

1/6/2026

36 6

Summary

Story summary

Wei Zhao, a researcher at Melbourne's Peter Doherty Institute for Infection and Immunity, proposed Crispr-Cas13 to treat and prevent influenza.
His team aims to use the Cas13 enzyme to target conserved influenza genome regions and inactivate viruses genetically.
Unlike standard antivirals, this approach could address multiple strains and function as both therapy and preventive measure.

1 of 1

Story summary

Wei Zhao, a researcher at Melbourne's Peter Doherty Institute for Infection and Immunity, proposed Crispr-Cas13 to treat and prevent influenza.
His team aims to use the Cas13 enzyme to target conserved influenza genome regions and inactivate viruses genetically.
Unlike standard antivirals, this approach could address multiple strains and function as both therapy and preventive measure.